Effects of A-GPC on Reaction Time and Cognitive Function
NCT ID: NCT03903250
Last Updated: 2020-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2019-03-25
2020-09-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Supplementation protocol: Participants will be randomly assigned into one of two treatments and will be given 4oz of either a placebo or active treatment mixed in orange flavored Gatorade everyday for 5 days. On Monday, participants will consume the beverage after testing is complete. Tuesday through Friday the beverage will be consumed as the participants arrive in the HPL.
On Mondays and Fridays, testing will be as follows: questionnaires, hemodynamic measures, reaction time testing, cognitive function testing via ImPACT, an acute exercise bout, reaction time testing, and cognitive function testing via ImPACT. On Tuesdays and Thursdays, participants will come check into the HPL for 30 minutes. On Wednesday, participants will come into the HPL to complete the acute exercise bout. To control their sleep to the best of our ability, participants are required to send emails every 30 minutes beginning at 10pm until their designated sleep time so the investigators know the participants are not asleep and gaining more than 5 hours of sleep.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sugar
100% soluble in liquid. 4 oz. taken in the morning of testing sessions.
Sugar
Taken orally in liquid form
A-GPC
100% soluble in liquid. 4 oz. taken in the morning of testing sessions.
A-GPC
Taken orally in liquid form
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A-GPC
Taken orally in liquid form
Sugar
Taken orally in liquid form
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants regularly sleep \>7.5 hours per night;
* Participants have not been consistently resistance training for the past 6 months;
* Participant has provided written and dated informed consent to participate in the study;
* Participant is willing and able to comply with the protocol;
* Participant is apparently healthy and free from disease, as determined by a health history questionnaire;
* Participants agrees to not drive or operate heavy machinery while under sleep deprivation as a result of the study (Tuesday-Saturday);
Exclusion Criteria
* Participant is medically prescribed by a physician to take over the counter medications including medications related to insomnia or sleep aids (such as melatonin);
* Participant is medically diagnosed with a mental health/psychological disorder or suspected of having a mental health/diagnostic disorder that would be influenced or made worse by sleep deprivation;
* Participant is allergic to any ingredient in the nutritional supplement or placebo;
* Participant may be pregnant, is pregnant, is trying to become pregnant, or is breastfeeding;
* Participant has a major exam or academic requirement that will fall during the sleep deprived portion of the study (Tuesday-Friday)
* Participant reports any unusual adverse events associated with this study that in consultation with the study investigators or their doctor recommends removal from the study;
* Participants fail to abstain from operating motor vehicles or heavy machinery;
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chemi Nutra, LLC.
UNKNOWN
University of Mary Hardin-Baylor
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lemuel W Taylor IV, PhD
Role: PRINCIPAL_INVESTIGATOR
UMHB Human Performance Lab
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UMHB Human Performance Lab
Belton, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGPC-1
Identifier Type: -
Identifier Source: org_study_id